ImmVira

ImmVira

Biotechnology Hong, Hk 15 employees
Employees
15
Contacts
4
Emails
4
Phones
2

ImmVira Overview

Headquarters
Hong, Hk
Phone Number
Available in AeroLeads
Industry
Biotechnology
Employees
15
Founded
2015

About ImmVira

VISION ABOVE AND BEYOND Immvira was founded in May of 2015 by Prof. Bernard Roizman of University of Chicago and Prof. Grace Zhou formerly a Research Associate Professor at University of Chicago, Prof. Thomas Shenk of Princeton University, Prof. Richard Whitley of University of Alabama, Prof. Ralph Weichselbaum of University of Chicago. Our mission is to develop a broad range of anti-cancer therapies based on genetically engineered viruses and augmented by cancer specific immune factors or chemotherapeutic agents that can be delivered intratumorally or systemically. Our lead candidate, a oHSV encoding IL12 and anti-PD-1Ab (T3) is designed to be administered by direct injection into the tumor mass. In murine tests it is more potent and would be expected to lack the toxicity associated with the systemic administration of immunomodulators alone. Product line 1 already entered clinical trials in January of 2019.

ImmVira Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
2
50.0% coverage

ImmVira Org Chart

Sample employees and titles
Name Title Contact
Wen Chen Innovex Medical - 董事会成员
Email
Xi (Demi) Zhang, Cpa, Frm Executive Vice President, Global
Email Phone
Junchen Diao, Ph.d. Healthcare Investor at Octagon Capital
Email
Edward Garmey Founder and Consultant, CMO Consulting
Email Phone

Employees by Management Level

Executive 3 profiles
Individual contributor 2 profiles
Manager 1 profile

Compare Similar Companies to ImmVira